Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Is Viking Therapeutics the Next Big Biotech Bet?
07:00pm, Friday, 01'st Aug 2025
Explore the exciting world of Viking Therapeutics (VKTX 0.28%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into ma
Viking Therapeutics Q2: Confidently Continuing The Recovery
10:15am, Friday, 25'th Jul 2025
Viking Therapeutics' stock has outperformed the S&P 500 since its April lows, marking a solid turnaround. The company's dual-track approach (injectables and oral) for VK2735 positions it well against
VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales
11:46am, Thursday, 24'th Jul 2025
Shares of Viking slide after Q2 loss widens to 58 cents per share on rising R&D and nil revenues, missing estimates by 14 cents.
Viking Therapeutics, Inc. (VKTX) Q2 2025 Earnings Call Transcript
09:45pm, Wednesday, 23'rd Jul 2025
Viking Therapeutics, Inc. (NASDAQ:VKTX ) Q2 2025 Earnings Conference Call July 23, 2025 4:30 PM ET Company Participants Brian Lian - President, CEO & Director Gregory Zante - Chief Financial Officer C
Viking Therapeutics Posts Wider Q2 Loss
06:46pm, Wednesday, 23'rd Jul 2025
Viking Therapeutics Posts Wider Q2 Loss
Viking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
04:05pm, Wednesday, 23'rd Jul 2025
Conference call scheduled for 4:30 p.m. ET today Phase 3 VANQUISH Registration Trials Underway for VK2735 in Obesity Phase 2 VENTURE-Oral Dosing Trial Enrollment Completed; Top-Line Results Expected 2
Better Growth Buy: Eli Lilly vs. Viking Therapeutics
07:15am, Tuesday, 22'nd Jul 2025
Eli Lilly (LLY -1.24%) and Viking Therapeutics (VKTX -0.12%) have garnered considerable attention over the past year due to their solid clinical progress. However, these drugmakers have also lagged th
Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect
10:41am, Monday, 21'st Jul 2025
With no revenue expected, VKTX's Q2 report is likely to have the spotlight on pipeline moves across its obesity drugs.
3 Monster Stocks in the Making to Buy Right Now
12:07am, Monday, 21'st Jul 2025
Where can you find the next monster stocks? Check out the biotech space.
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?
04:48am, Sunday, 20'th Jul 2025
Investors seeking stocks that can put up dramatic gains in a short amount of time can find what they're looking for in the biotechnology industry. Investment bank analysts on Wall Street have tagged a
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
06:09am, Saturday, 19'th Jul 2025
Any investor who owned Viking Therapeutics (VKTX -0.23%) before November of last year is sure to be disappointed and maybe even a little worried. Shares are down nearly 60% since October last year and
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?
10:30am, Friday, 18'th Jul 2025
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know
06:45pm, Thursday, 17'th Jul 2025
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $32.07, representing a +1.39% change from its previous close.
Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025
04:05pm, Wednesday, 16'th Jul 2025
Conference Call Scheduled for Wednesday, July 23 at 4:30 p.m. Eastern Time SAN DIEGO , July 16, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical
The Best Stocks to Invest $1,000 In Right Now
04:40am, Tuesday, 15'th Jul 2025
If you have $1,000 to invest right now, you may be wondering where to get started. You could buy stocks that are flying high and try to get in on the momentum, or you could look for bargains among sto
